This Biotech Stock 135% Jump Trims $44M: What Now Today
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
A quick guide helps you compare 401(k) options for your 30s, focusing on fees, employer matches, and potential tax outcomes.
24,750 articlesA biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
When a chief operating officer sells shares, investors often wonder what it really means. This guide explains how to ...
Federal safety regulators announce a recall of about 12,830 toddler tower stools across three brands after dozens of ...
Districts have spent tens of millions to ban phones in classrooms, but a sweeping study finds little to no improvemen...
A notable fund liquidated its entire Ascendis Pharma stake, signaling a strategic rotation in a volatile biotech sect...
Maze Therapeutics stock still faces mixed signals from the market: a strong rally after a March dip, paired with a no...
A new industry report shows on-time flight arrivals at their worst since 2014, pushed by higher fuel costs and volati...
Equities cling to gains near all-time highs as hedge funds maintain elevated short positions. A possible Iran deal fu...
A growth stock has fallen over 40% in 2026, testing the patience of investors. This guide breaks down how to assess w...
Global stock markets push to record highs, delivering a wealth boom for investors. But analysts caution that rising i...
AMD has sprinted ahead in a rapid rally. This guide weighs whether the late advanced micro devices story still offers...
As AI stocks push valuations higher, a simple growth-based framework suggests paying earnings still cheap can still w...